Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Clinical and Diagnostic Laboratory Immunology|April 1, 1998
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigensL Chiarantini, D Matteucci, M Pistello, et al.
Journal of Virology|December 1, 1994
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunityS Lombardi, C Garzelli, M Pistello, et al.
Journal of Virology|October 29, 1997
Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boostedD Matteucci, M Pistello, P Mazzetti, et al.
Journal of Medical Virology|May 22, 2001
TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cellsF Maggi, C Fornai, L Zaccaro, et al.
The Journal of Infectious Diseases|August 7, 1999
High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatmentF Maggi, C Fornai, A Morrica, et al.
Journal of Biological Regulators and Homeostatic Agents|October 2, 2003
Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patientsF Maggi, C Fornai, E Tempestini, et al.
Journal of Clinical Microbiology|January 1, 1994
Prevalence of hepatitis C virus genotypes in ItalyM Pistello, F Maggi, L Vatteroni, et al.
Journal of Virological Methods|March 26, 1999
Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated methodA Morrica, M Giorgi, F Maggi, et al.
AIDS Research and Human Retroviruses|January 10, 2002
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapyE Riva, M Pistello, P Narciso, et al.
Journal of Virology|November 17, 2001
Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infectionF Maggi, M Pistello, M Vatteroni, et al.
Pageof 8